l General Information |
Product Name | RO-3306 |
General description | RO-3306 is an ATP-competitive, and selective CDK1 inhibitor. |
Synonym | (5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylamino)-1,3-thiazol-4-one; RO3306; RO 3306 |
Purity | ≥99.0%(HPLC) | CAS Number | 872573-93-8 |
Formula | C18H13N3OS2 | Molecular Weight | 351.45 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Pink solid |
Solubility(25℃) | DMSO | ≥10mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | RO-3306 is an ATP-competitive, and selective CDK1 inhibitor (Ki = 20 nM), about 15-fold more selectivity against a diverse panel of human kinases. |
l Packaging & Storage |
Packaging | 5mg; 10mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
